Cleared Abbreviated

K121803 - INTRAVASCULAR ADMINISTRATION SET

K121803 is an FDA 510(k) clearance for INTRAVASCULAR ADMINISTRATION SET, manufactured by Acta Medical, LLC. The device is a Class 2 General Hospital device with product code FPA cleared through the Abbreviated 510(k) pathway after a 183-day FDA review.

K121803 · Acta Medical, LLC · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2012
Decision
183d
Days
Class 2
Risk

K121803 is an FDA 510(k) clearance for the INTRAVASCULAR ADMINISTRATION SET. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Acta Medical, LLC (Flemington, US). The FDA issued a Cleared decision on December 19, 2012 after a review of 183 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Acta Medical, LLC devices

FDA 510(k) Submission Details - K121803

510(k) Number K121803 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 19, 2012
Decision Date December 19, 2012
Days to Decision 183 days
Submission Type Abbreviated
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
54d slower than avg
Panel avg: 129d · This submission: 183d
Pathway characteristics
Standards-based clearance path.

FPA Device Classification - Class 2, Special Controls

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 513
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K121803.
MZ1000
K132413 · Care Fusion · Aug 2013
INTERLINK SYSTEM BURETROL SOLUTION SETS, INTERLINK SYSTEM BURETROL SOLUTION SETS, CONTINUED, CLEARLINK SYSTEM BURETROL S
K123874 · Baxter Healthcare Corp · Jan 2013
INTERLINK SYSTEM LEVER LOCK CANNULA WITH CHECK VALVE, SECONDARY MEDICATION SETS, SOLUTION SETS, CONTINU-FLO SOLUTION SET
K123868 · Baxter Healthcare Corp · Jan 2013
NIPRO HUBER INFUSION SET, EXCEL HUBER INFUSION SET
K113471 · Nipro Medical Corporation · Oct 2012
NIPRO SAFE TOUCH HUBER INFUSION SET
K113470 · Nipro Medical Corporation · Oct 2012
FLOWEASE [SUBCUTANEOUS] INFUSION SET
K121092 · Baxter Healthcare Corp · Jun 2012